focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Wed, 08th Dec 2021 11:45

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Rockhopper Exploration PLC, up 22% at 6.38 pence, 12-month range 4.50p-12.50p. The oil & gas exploration and production company says Navitas Petroleum LP is to enter its Sea Lion oil project in the Falkland Islands. Navitas replaces Harbour Energy PLC as Rockhopper's partner in the project.

----------

Equals Group PLC, up 12% at 70.40p, 12-month range 26.10p-73.00. The fintech payments firm says it has "significantly exceeded" its full-year expectations for both adjusted earnings and revenue. Group revenue for the year to date is GBP40.4 million, up 51% from GBP26.8 million for the same period in 2020. The strong revenue performance means increased gross profit and earnings, and Equals says it has exceeded its own full-year profitability forecasts, but does not provide a figure.

----------

Clinigen Group PLC, up 10% at 901.00p, 12-month range 541.50p-912.00p. Shares hit 12-month high after the pharmaceuticals and services provider agrees to be taken private by European investment firm Triton Funds in a GBP1.2 billion deal. Under the terms, Clinigen shareholders will receive 883p a share in cash. This is a 41% premium to the ex-dividend closing share price on December 1, which was the last business day before takeover talks were first announced. Clinigen shareholders will also be entitled to receive the previously declared final dividend of 5.46p a share.

----------

AIM - LOSERS

----------

Byotrol PLC, down 16% at 4.22p, 12-month range 4.00p-7.70p. Shares in the antimicrobial technologies company hit fresh 12-month low after profit warning and says its first half performance was below expectations. For six months to September 30, swings to pretax loss of GBP141,000 from GBP1.0 million profit year before. "Whilst we expect to be both profitable and cash generative in the second half of the year, with these uncertainties it is difficult to predict the quantum at this juncture. At present we are expecting IP sales to offset the majority of the anticipated shortfall in profit on product sale, but projecting the timing of IP sales is even more uncertain, so we feel it prudent to now reduce market guidance for the current financial year," it says.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Nov 2020 08:19

LONDON BRIEFING: M&A Gives Further Boost To Virus-Weary Market

LONDON BRIEFING: M&A Gives Further Boost To Virus-Weary Market

Read more
23 Nov 2020 13:28

Monday broker round-up

(Sharecast News) - DWF Group: Liberum initiates at hold with a target price of 90p.

Read more
19 Nov 2020 16:00

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
10 Nov 2020 13:17

Tuesday broker round-up

(Sharecast News) - On the Beach: Citigroup downgrades to neutral with a target price of 370p.

Read more
10 Nov 2020 11:44

IN BRIEF: Clinigen Says Totect Gets FDA Approval As Breast Cancer Drug

IN BRIEF: Clinigen Says Totect Gets FDA Approval As Breast Cancer Drug

Read more
29 Oct 2020 16:01

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
28 Oct 2020 15:58

UK DIRECTOR DEALINGS SUMMARY: Next Director Sells GBP780,000 In Shares

UK DIRECTOR DEALINGS SUMMARY: Next Director Sells GBP780,000 In Shares

Read more
23 Oct 2020 16:04

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
29 Sep 2020 12:14

Synairgen Progresses Covid-19 Treatment As Expenses Increase

Synairgen Progresses Covid-19 Treatment As Expenses Increase

Read more
17 Sep 2020 11:40

Clinigen Ups Final Dividend After Seeing Profit Almost Double

Clinigen Ups Final Dividend After Seeing Profit Almost Double

Read more
16 Sep 2020 16:08

UK EXECUTIVE CHANGE SUMMARY: Cora Hires Ex-Centamin Exploration Exec

UK EXECUTIVE CHANGE SUMMARY: Cora Hires Ex-Centamin Exploration Exec

Read more
10 Sep 2020 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
23 Jul 2020 14:25

Thursday broker round-up

(Sharecast News) - Stagecoach Group: Peel Hunt upgrades to buy with a target price of 70.0p.

Read more
14 Jul 2020 11:04

Clinigen Annual Profit Rise To Be At Lower End Of Guidance

Clinigen Annual Profit Rise To Be At Lower End Of Guidance

Read more
14 Jul 2020 09:49

UK BROKER RATINGS SUMMARY: RBC Upgrades IMI And Downgrades Rotork

UK BROKER RATINGS SUMMARY: RBC Upgrades IMI And Downgrades Rotork

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.